Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Dr Lisa Rothmann
Dr Lisa Rothmann, a plant disease epidemiologist from the University of the Free State (UFS), has been nominated in the TW Kambule-NSTF Award: Emerging Researcher category for this year’s NSTF-South32 Awards.

Dr Lisa Rothmann, a plant disease epidemiologist from the University of the Free State (UFS) who was nominated in the TW Kambule-NSTF Award: Emerging Researcher category for this year’s NSTF-South32 Awards, says that the nomination is a reminder that service through science matters.

“I am humbled by the nomination. For me, it reflects not just individual recognition, but also the shared effort of the team of postgraduate academics, research assistants, partners, and farmers with whom I've had the privilege to work with. It is affirming to see plant pathology and field-based research recognised in this way; it highlights the consistent (hard) work we do to make a meaningful contribution to agriculture and to serve the grain industry and farmers,” says Dr Rothmann. 

She was nominated by Grain South Africa (Grain SA), with whom she has been working closely since 2018 to contribute research that aligns with the organisation’s mission to strengthen the grain sector. They play a key role in supporting sustainable grain production and farmer development. 

Dr Rothmann, who is one of eight UFS researchers and a research team nominated for the NSTF-South32 Awards – also known as the ‘Science Oscars’ – is nominated for her contribution to interdisciplinary, team-based research to develop practical solutions for plant diseases in order to protect crops and empower communities. 

 

Motivation to keep growing

The Senior Lecturer in the Department of Plant Sciences within the Faculty of Natural and Agricultural Sciences (NAS) says that while she is proud of the work she has done, she sees this recognition as a team effort. Says Dr Rothmann: “It motivates me to keep growing as a researcher, rooted in impact and integrity. I’m not a prolific peer-reviewed publisher; my academic record includes 10 journal articles and one book chapter, but I have written around 50 popular articles – often as a solo author, in collaboration with postgraduates and peers.” 

“These pieces translate plant pathology topics such as the Sclerotinia life cycle, disease surveillance, and management into accessible information for producers and the public. To me, this nomination is a symbol that making a meaningful impact doesn't only come from journal impact factors. This nomination has reminded me that building a career in academia is a relay, not a race, and that lasting impact comes from investing in others.”

As a plant disease epidemiologist, she specialises in field pathology – an area of plant pathology that explores how disease epidemics in crops develop, spread, and can be effectively managed within agricultural systems. Their work centres on understanding and managing Sclerotinia diseases in oilseed and protein crops such as canola, soybean, and sunflower, as well as disease surveillance in key grain crops including dry bean, sorghum, and sunflower.

 

New research

After participating in the US-based National Sclerotinia Initiative in 2017, she was inspired to establish a South African Sclerotinia Research Network with the support of Grain SA, creating a platform for researcher collaboration, farmer engagement, and the development of on-farm management strategies. Over time, explains Dr Rothmann, their research has expanded to include cultivar screening, national disease surveys, fungicide registration trials, and the development of disease-assessment tools. More recently, they have embedded sociological surveys into sorghum disease work to better understand farmers’ knowledge and needs, ensuring that research remains practical and co-created with producers.

According to Dr Rothmann, they have been privileged to work in a space that supports producers and protects crops through applied plant disease management strategies. While high-value crops often attract attention due to export markets, the grain that feed the nation forms the backbone of food security. As part of their new research, Dr Rothman and the research team are currently contributing to the Sorghum Cluster Initiative's pre-breeding programme, where they have screened 160 accessions for diseases to support future cultivar development. 

They are also going to explore how both emerging and commercial farmers will adopt these new cultivars. She is actively seeking collaborators in sociology/psychology or similar fields to better understand farmers’ decision-making. They are developing a plant disease dashboard to map disease occurrences across South Africa – an effort aligned with the Plant Health (Phytosanitary) Act 35 of 2024 to help guide appropriate disease risk categorisation. In the long term, concludes Dr Rothmann, they hope to establish a diagnostic hub for central South Africa in partnership with Agricultural Research Council-Grain Crops to strengthen local disease identification and support producers in real time.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept